GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (ROCO:4743) » Definitions » PB Ratio

Oneness Biotech Co (ROCO:4743) PB Ratio : 2.41 (As of Apr. 16, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Oneness Biotech Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-16), Oneness Biotech Co's share price is NT$62.10. Oneness Biotech Co's Book Value per Share for the quarter that ended in Dec. 2024 was NT$25.73. Hence, Oneness Biotech Co's PB Ratio of today is 2.41.

Good Sign:

Oneness Biotech Co Ltd stock PB Ratio (=2.24) is close to 5-year low of 2.19.

The historical rank and industry rank for Oneness Biotech Co's PB Ratio or its related term are showing as below:

ROCO:4743' s PB Ratio Range Over the Past 10 Years
Min: 1.18   Med: 3.04   Max: 16.19
Current: 2.42

During the past 13 years, Oneness Biotech Co's highest PB Ratio was 16.19. The lowest was 1.18. And the median was 3.04.

ROCO:4743's PB Ratio is ranked worse than
54.98% of 1284 companies
in the Biotechnology industry
Industry Median: 2.1 vs ROCO:4743: 2.42

During the past 12 months, Oneness Biotech Co's average Book Value Per Share Growth Rate was -12.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -5.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 7.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 15.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Oneness Biotech Co was 52.20% per year. The lowest was -10.00% per year. And the median was 10.50% per year.

Back to Basics: PB Ratio


Oneness Biotech Co PB Ratio Historical Data

The historical data trend for Oneness Biotech Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co PB Ratio Chart

Oneness Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.62 7.87 6.55 6.28 3.39

Oneness Biotech Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.28 5.74 5.53 5.22 3.39

Competitive Comparison of Oneness Biotech Co's PB Ratio

For the Biotechnology subindustry, Oneness Biotech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oneness Biotech Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oneness Biotech Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Oneness Biotech Co's PB Ratio falls into.


;
;

Oneness Biotech Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Oneness Biotech Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=62.10/25.728
=2.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Oneness Biotech Co  (ROCO:4743) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Oneness Biotech Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Oneness Biotech Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oneness Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 66, Section. 1, Zhongxiao West Road, 35th Floor, Zhongzheng District, Taipei, TWN, 100
Oneness Biotech Co Ltd is a Taiwan based biopharmaceutical company. The company develops healthcare drugs. Its products are used for chronic diabetic, dengue hemorrhagic fever, and Rheumatoid Arthritis. The company's operating segment includes New Drug Research and Development and Agricultural Products Cultivation. It generates maximum revenue from New Drug Research and Development segment.

Oneness Biotech Co Headlines

No Headlines